On the correlation between the hepatocarcinogenicity of the carcinogen, N-2-fluorenylacetamide, and its metabolic activation by the rat.
D000081:Acetamides; D002759:Adenoma, Bile Duct / Q000473:pathology; D000818:Animals; D001646:Bile / Q000032:analysis; D002247:Carbon Isotopes; D002273:Carcinogens / Q000652:urine; D006528:Carcinoma, Hepatocellular / Q000473:pathology; D002850:Chromatography, Gel; D002852:Chromatography, Ion Exchange; D005260:Female; D005449:Fluorenes / Q000652:urine; D006877:Hydroxamic Acids / Q000378:metabolism; D006898:Hydroxylamines / Q000378:metabolism; D006900:Hydroxylation; D008099:Liver / Q000201:enzymology; D008113:Liver Neoplasms / Q000139:chemically induced*; D008325:Mammary Neoplasms, Experimental; D009374:Neoplasms, Experimental; D013045:Species Specificity; D013466:Sulfurtransferases / Q000378:metabolism
D000081:Acetamides; D002247:Carbon Isotopes; D002273:Carcinogens; D005449:Fluorenes; D006877:Hydroxamic Acids; D006898:Hydroxylamines; D013466:Sulfurtransferases